SPOTLIGHT -
Treatment Options Expanding in Renal Carcinoma
First- and second-line treatment of clear cell RCC has changed dramatically, Dr. Eric Jonasch said during the NCCN Annual Conference in Orlando.
Evolving Treatment for Advanced Melanoma: More Questions Than Answers
At the NCCN Annual Conference in Orlando, Dr. April Salama discussed targeted treatment options in first- and second-line therapy for advanced melanoma.
